Status:

RECRUITING

90Yttrium Colloid for the Treatment of Cystic Sellar/Parasellar Tumors

Lead Sponsor:

David Clarke

Conditions:

Cystic Tumors of the Sellar/Parasellar Region

Eligibility:

All Genders

17+ years

Phase:

PHASE3

Brief Summary

There is no consensus in the literature on the best way to treat cystic lesions of the pituitary area. Patients who are symptomatic from these tumours are rare. The cystic form of tumours present spec...

Detailed Description

Surgical procedures will be performed as standard of care. The treating neurosurgeon (Dr. David B. Clarke) will determine surgical parameters based on his clinical expertise.

Eligibility Criteria

Criteria

Ages Eligible for Study: 17 years of age or older Genders Eligible for Study: Both Accepts Healthy Volunteers: No

Inclusion Criteria

Patients who meet all of the following criteria are eligible for enrollment as study participants:

  1. Patients 17 years of age or older.
  2. Cystic sellar, suprasellar, parasellar or intrasellar masses diagnosed by histology, cytology or neuroimaging.
  3. Tumour measurements and/or tumour volume can be calculated.
  4. Patients who require surgical intervention as determined by the treating neurosurgeon.
  5. Being a patient managed in the Halifax Neuropituitary Program surgical clinic.
  6. Willingness to undergo surgery and give informed surgical consent.
  7. Willingness to provide informed consent for study participation.

Exclusion Criteria

Patients who meet any of these criteria are not eligible for enrollment as study participants:

  1. Neurosurgeon's assessment that surgical procedures hold unacceptable operative risk.
  2. Having a solid tumour.
  3. Pregnant or breast feeding at time of surgical consent and/or surgery.
  4. Hypersensitivity, allergies or contraindication to the used radiopharmaceutical agent (90yttrium colloid).

Key Trial Info

Start Date :

June 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 31 2031

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT02081768

Start Date

June 1 2014

End Date

October 31 2031

Last Update

February 20 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Halifax Infirmary

Halifax, Nova Scotia, Canada, B3H 3A7

90Yttrium Colloid for the Treatment of Cystic Sellar/Parasellar Tumors | DecenTrialz